See more.
Know more.
Do better.
Know more.
Do better.
How it works
FreeStyle LibreLink is integrated with insulin pens, one scan connects insulin doses and glucose.
Watch this video to help your patients' start using their smart connected insulin pens with the FreeStyle LibreLink app.
Benefits
Benefits of connecting NovoPen® 6 or NovoPen Echo® Plus
with FreeStyle LibreLink & LibreView₼
See average total daily short-acting and long-acting insulin doses at a glance
Highlights important information such as Average Glucose, percentage of Time In Target and Low Glucose Events.
Easily see average total daily insulin usage over a 14-day period.
See insulin and glucose data together to support more efficient patient consultations
See color-coded short- and long-acting insulin and glucose data side-by-side with the AGP graph.
Helps you help your patients to adjust insulin doses.
One app connects it all.
Easy Integration
Insulin doses recorded from the compatible smart connected insulin pen1 can be transferred to the FreeStyle LibreLink app2 with a scan.
Easy Insights4
On-demand, remote access to glucose and insulin reports for more informed consultations.
Easy connection
Reassurance and peace of mind for family members5 with the LibreLinkUp app
References & Disclaimers
Images are for illustrative purposes only. Not real patient or data.
1. The FreeStyle LibreLink is only compatible with NovoPen® 6 and NovoPen Echo® Plus.
2. The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink may require registration with LibreView.
3. In order for your patients to transfer their recorded insulin doses from their compatible smart insulin pen to the FreeStyle LibreLink app, they should hold the pen to the top of the iPhone or hold the pen to the back of the Android Phone. The user may need to try scanning with different areas to find the right spot.
4. Unger J., Postgrad Med. (2020): https://doi.org/10.1080/00325481.2020.1744393
5. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142
₼ The LibreView website is only compatible with certain operating systems and browsers. Please check www.libreview.com for additional information.
The sensor housing, FreeStyle Libre, and related brand marks are marks of Abbott. NovoPen® 6 and NovoPen Echo® Plus are registered trademarks owned by Novo Nordisk.
NovoPen® 6 and NovoPen Echo® Plus are CE-marked medical devices (0123). Manufacturer: Novo Nordisk.
Please be aware that correct use of NovoPen® 6 and NovoPen Echo® Plus is important for accurate dosing of the drug. Please ensure that your patient is instructed on correct use of NovoPen® 6 and NovoPen Echo® Plus.
ADC-94985 v1.0 10/24
STAY CONNECTED